Difference between revisions of "Team:HZAU-China/Results"

Line 808: Line 808:
 
         <div class="zhengwen">
 
         <div class="zhengwen">
 
             <div id="float01" class="cur">
 
             <div id="float01" class="cur">
                <div class="h1">Chassis</div>
+
                <div class="h1">Chassis</div>
 
                 <div class="h2"><i>sifA</i> knock out</div>
 
                 <div class="h2"><i>sifA</i> knock out</div>
 
                 <p>SifA maintains the integrity of <i>Salmonella</i>-containing vacuole (SCV) where <i>Salmonella</i>
 
                 <p>SifA maintains the integrity of <i>Salmonella</i>-containing vacuole (SCV) where <i>Salmonella</i>
Line 825: Line 825:
 
                     <img src="https://static.igem.org/mediawiki/2018/7/79/T--HZAU-China--results1.png" width=100% alt="">
 
                     <img src="https://static.igem.org/mediawiki/2018/7/79/T--HZAU-China--results1.png" width=100% alt="">
 
                 </div>
 
                 </div>
                 <p><b>Figure 1.</b> PCR verification of <i>sifA</i> gene knock out. Lane 1 refers to mutant candidate.
+
                 <p><b>Figure 1.</b> PCR verification of <i>sifA</i> gene knock out. Lane 1 refers to Δ<i>sifA</i> mutant.
 
                     Lane 2 refers
 
                     Lane 2 refers
                     to WT <i>Salmonella enterica</i> var. Typhimurium SL1344 as a control.</p>
+
                     to WT <i>Salmonella enterica</i> serovar Typhimurium strain SL1344 as a control.</p>
 
                 <div style="width: 90%; margin: 20px auto">
 
                 <div style="width: 90%; margin: 20px auto">
 
                     <img src="https://static.igem.org/mediawiki/2018/0/07/T--HZAU-China--results2.png" width=100% alt="">
 
                     <img src="https://static.igem.org/mediawiki/2018/0/07/T--HZAU-China--results2.png" width=100% alt="">
Line 836: Line 836:
  
 
                 <div class="h2">Safety</div>
 
                 <div class="h2">Safety</div>
                 <p>SifA is essential for maintaining vacuolar membrane stability. Cytosolic bacteria can be generated
+
                 <p>SifA is essential for maintaining vacuolar membrane stability. Cytosolic bacterium can be generated
                     by the function loss of <i>Salmonella</i>-containing vacuole (SCV). This population of bacteria was
+
                     by the function loss of SCV. This population of bacterium was
 
                     easily
 
                     easily
 
                     recognized and cleaned up by macrophage. Hence, Δ<i>sifA</i> mutant decrease the toxicity to the
 
                     recognized and cleaned up by macrophage. Hence, Δ<i>sifA</i> mutant decrease the toxicity to the
Line 849: Line 849:
 
                 <p><b>Figure 3.</b> Microscopy of immortalized bone-marrow-derived macrophages (iBMDM) infected with
 
                 <p><b>Figure 3.</b> Microscopy of immortalized bone-marrow-derived macrophages (iBMDM) infected with
 
                     the Δ<i>sifA</i>
 
                     the Δ<i>sifA</i>
                     mutant and WT <i>Salmonella</i>, respectively. These strains contain high copy number plasmids to
+
                     mutant and WT <i>Salmonella</i> SL1344, respectively. These strains contain high copy number plasmids to
 
                     express RFP constitutively.</p>
 
                     express RFP constitutively.</p>
 
                 <div class="collapseDiv">
 
                 <div class="collapseDiv">
Line 857: Line 857:
 
                         <b>Preparation of Cells for Infection</b><br>
 
                         <b>Preparation of Cells for Infection</b><br>
 
                         1. Grow iBMDMs in a humidified 37 °C, 5% CO<sub>2</sub> tissue-culture incubator.<br>
 
                         1. Grow iBMDMs in a humidified 37 °C, 5% CO<sub>2</sub> tissue-culture incubator.<br>
                         2. Count the cells using a hemocytometer. Seed in 24-well (5 × 10^4 per well) and grow
+
                         2. Count the cells using a hemocytometer. Seed in 24-well (5×10^4 per well) and grow
 
                         overnight .<br>
 
                         overnight .<br>
                         <b>Preparation of Bacteria</b>
+
                         <b>Preparation of the Bacterial Cells</b>
                         1. Grow bacteria overnight 16 h in 2 mL LB in a 15-mL tube. Incubate at 37 °C in a shaking
+
                         1. Grow bacterial cells overnight 16 h in 2 mL LB in a 15-mL tube. Incubate at 37 °C in a shaking
 
                         incubator (200 rpm).<br>
 
                         incubator (200 rpm).<br>
                         2. Subculture bacteria by transferring 300 μL of the overnight culture into 5 mL of LB in a
+
                         2. Subculture bacterial cells by transferring 300 μL of the overnight culture into 5 mL of LB in a
 
                         loosely capped 50-mL tube. Incubate at 37 °C in a shaking incubator (200 rpm) to late log
 
                         loosely capped 50-mL tube. Incubate at 37 °C in a shaking incubator (200 rpm) to late log
 
                         phase.<br>
 
                         phase.<br>
                         3. Pellet 1 mL of the <i>Salmonella</i> subculture by centrifugation at 1000 g in a microfuge
+
                         3. Pellet 1 mL of the <i>Salmonella</i> bacteria cells subculture by centrifugation at 1,000×g in a microfuge
 
                         for 2
 
                         for 2
 
                         min at room temperature.<br>
 
                         min at room temperature.<br>
Line 871: Line 871:
 
                         <b>Infection</b>
 
                         <b>Infection</b>
 
                         1. Aspirate media and rinse the monolayer twice with PBS.<br>
 
                         1. Aspirate media and rinse the monolayer twice with PBS.<br>
                         2. Inoculate cells with bacteria (MOI = 20) by adding bacteria directly to the cell-culture
+
                         2. Inoculate cells with bacterial cells (MOI = 20) by adding bacterial cells directly to the cell-culture
                         supernatant. Centrifugation at 110 g for 5 min at room temperature.<br>
+
                         supernatant. Centrifugate at 110 g for 5 min at room temperature.<br>
 
                         3. Incubate for 25 min at 37 °C in 5% CO<sub>2</sub>.<br>
 
                         3. Incubate for 25 min at 37 °C in 5% CO<sub>2</sub>.<br>
                         4. Aspirate media and rinse the monolayer twice with PBS, to remove extracellular bacteria.<br>
+
                         4. Aspirate media and rinse the monolayer twice with PBS, to remove extracellular bacterial cells.<br>
 
                         5. Add fresh GM containing 100 μg/mL gentamicin and incubate for 2 h at 37 °C in 5% CO<sub>2</sub>.<br>
 
                         5. Add fresh GM containing 100 μg/mL gentamicin and incubate for 2 h at 37 °C in 5% CO<sub>2</sub>.<br>
 
                         6. Replace GM with fresh GM containing 20 μg/mL gentamicin for remainder of experiment.<br>
 
                         6. Replace GM with fresh GM containing 20 μg/mL gentamicin for remainder of experiment.<br>
Line 886: Line 886:
 
                 <p>RGD motif can specifically bind to alpha V beta 3 (αVβ3), a well-known biomarker on the surface of
 
                 <p>RGD motif can specifically bind to alpha V beta 3 (αVβ3), a well-known biomarker on the surface of
 
                     tumor cells. We express RGD motif fused with OmpA to surface display it on the outer membrane of
 
                     tumor cells. We express RGD motif fused with OmpA to surface display it on the outer membrane of
                     bacteria. Microscopy shows that bacteria expressed Lpp-OmpA-RGD induced by 0.1 mM IPTG can bind to
+
                     bacterial cells. Microscopy shows that bacterial cells expressed Lpp-OmpA-RGD induced by 0.1 mM IPTG can bind to
                     αVβ3-positive MDA-MB-231 cell line. The location of bacteria is pointed by red arrow (<b>Figure 4</b>).
+
                     αVβ3-positive MDA-MB-231 cell line. The location of bacterial cells is pointed by red arrow (<b>Figure 4</b>).
 
                     But cannot bind to αVβ3-negative MCF7 cell line (<b>Figure 5</b>). These results demonstrated that
 
                     But cannot bind to αVβ3-negative MCF7 cell line (<b>Figure 5</b>). These results demonstrated that
                     bacteria gain the function of tumor targeting though display RGD motif. </p>
+
                     the bacterium gain the function of tumor targeting though display RGD motif. </p>
 
                 <div style="width: 90%; margin: 0px auto">
 
                 <div style="width: 90%; margin: 0px auto">
 
                     <img src="https://static.igem.org/mediawiki/2018/b/b1/T--HZAU-China--Improve2.png" width=100% alt="">
 
                     <img src="https://static.igem.org/mediawiki/2018/b/b1/T--HZAU-China--Improve2.png" width=100% alt="">
Line 895: Line 895:
 
                 <p><b>Figure 4.</b> Microscopy of αVβ3-positive MDA-MB-231 cell line were incubated with <i>E. coli</i>
 
                 <p><b>Figure 4.</b> Microscopy of αVβ3-positive MDA-MB-231 cell line were incubated with <i>E. coli</i>
 
                     which
 
                     which
                     constructive expressed RFP and inductively expressed RGD motif under the control of lac promoter. </p>
+
                     constructive expressed RFP and inductively expressed RGD motif under the control of P<sup><i>lac</i></sup>. </p>
 
                 <div style="width: 90%; margin: 0px auto">
 
                 <div style="width: 90%; margin: 0px auto">
 
                     <img src="https://static.igem.org/mediawiki/2018/c/cf/T--HZAU-China--Improve3.png" width=100% alt="">
 
                     <img src="https://static.igem.org/mediawiki/2018/c/cf/T--HZAU-China--Improve3.png" width=100% alt="">
Line 910: Line 910:
 
                         2. Count the cells using a hemocytometer. Seed in 24-well (1.5× 10^5 per well) and grow
 
                         2. Count the cells using a hemocytometer. Seed in 24-well (1.5× 10^5 per well) and grow
 
                         overnight.<br>
 
                         overnight.<br>
                         <b>Preparation of Bacteria</b>
+
                         <b>Preparation of Bacterial cells</b>
                         1. Grow bacteria overnight 14 h in 2 mL LB in a 15-mL tube. Incubate at 37 °C in a shaking
+
                         1. Grow bacterial cells overnight 14 h in 2 mL LB in a 15-mL tube. Incubate at 37 °C in a shaking
 
                         incubator (200 rpm).<br>
 
                         incubator (200 rpm).<br>
                         2. Subculture bacteria by transferring 300 μL of the overnight culture into 5 mL of LB
+
                         2. Subculture bacterial cells by transferring 300 μL of the overnight culture into 5 mL of LB
 
                         containing 0.1 mM IPTG in a loosely capped 50-mL tube. Incubate at 37 °C in a shaking incubator
 
                         containing 0.1 mM IPTG in a loosely capped 50-mL tube. Incubate at 37 °C in a shaking incubator
 
                         (200 rpm) to early stationary phase.<br>
 
                         (200 rpm) to early stationary phase.<br>
                         3. Pellet 1 mL of the bacteria subculture by centrifugation at 1000 g in a microfuge for 2 min
+
                         3. Pellet 1 mL of the bacterial cells subculture by centrifugation at 1000 g in a microfuge for 2 min
 
                         at room temperature.<br>
 
                         at room temperature.<br>
 
                         4. Remove 900 μL of supernatant and gently resuspend the pellet in 900 μL PBS.<br>
 
                         4. Remove 900 μL of supernatant and gently resuspend the pellet in 900 μL PBS.<br>
 
                         <b>Infection</b>
 
                         <b>Infection</b>
 
                         1. Aspirate media and rinse the monolayer twice with PBS.<br>
 
                         1. Aspirate media and rinse the monolayer twice with PBS.<br>
                         2. Inoculate cells with bacteria (MOI = 100) by adding bacteria directly to the cell-culture
+
                         2. Inoculate cells with bacterial cells (MOI = 100) by adding bacterial cells directly to the cell-culture
 
                         supernatant.<br>
 
                         supernatant.<br>
 
                         3. Incubate for 1.5 h at 37 °C in 5% CO<sub>2</sub>.<br>
 
                         3. Incubate for 1.5 h at 37 °C in 5% CO<sub>2</sub>.<br>
Line 932: Line 932:
 
                 <div class="h1">Function of GSDMD</div>
 
                 <div class="h1">Function of GSDMD</div>
 
                 <div class="h2">The N-terminal of GSDMD performs the function of cell pyroptosis</div>
 
                 <div class="h2">The N-terminal of GSDMD performs the function of cell pyroptosis</div>
                 <p>We fused eGFP with GSDMD-N275 and GSDMD FL (full length), respectively. Then the corresponding
+
                 <p>We fused eGFP with GSDMD-N275 (N-terminal 275 amino acid) and GSDMD FL (full length), respectively. Then the corresponding
 
                     plasmids were transfected into Hela GSDMD KO cell. Cell microscopy showed that the cells
 
                     plasmids were transfected into Hela GSDMD KO cell. Cell microscopy showed that the cells
 
                     transfected with GSDMD-N275 underwent pyroptosis while the cells with GSDMD FL did not (<b>Figure 6</b>).
 
                     transfected with GSDMD-N275 underwent pyroptosis while the cells with GSDMD FL did not (<b>Figure 6</b>).
                     We also tested the cell viability through an ATP assay (CellTiter-Glo® Luminescent Cell Viability
+
                     We also tested the cell viability through an ATP assay (CellTiter-Glo<sup>®</sup> Luminescent Cell Viability
                     Assay) and demonstrated that GSDMD-N275 and mutants of GSDMD FL have different ability to induce
+
                     Assay) and demonstrated that GSDMD-N275 and mutants of GSDMD FL have different abilities to induce
 
                     pyroptosis (<b>Figure 7</b>).</p>
 
                     pyroptosis (<b>Figure 7</b>).</p>
 
                 <div style="width: 90%; margin: 0px auto">
 
                 <div style="width: 90%; margin: 0px auto">
 
                     <img src="https://static.igem.org/mediawiki/2018/7/7b/T--HZAU-China--results6.png" width=100% alt="">
 
                     <img src="https://static.igem.org/mediawiki/2018/7/7b/T--HZAU-China--results6.png" width=100% alt="">
 
                 </div>
 
                 </div>
                 <p><b>Figure 6.</b> Microscopy of the Hela GSDMD KO cells transfected with pCS2-eGFP-GSDMD FL and
+
                 <p><b>Figure 6.</b> Microscopy of the Hela GSDMD KO cells transfected with pCS2-eGFP-GSDMD FL (above) and
                     pCS2-eGFP-GSDMD-N275, respectively. Pyroptotic cells are pointed by red arrow.</p>
+
                     pCS2-eGFP-GSDMD-N275 (left), respectively. Pyroptotic cells are pointed by red arrow.</p>
 
                 <div class="collapseDiv">
 
                 <div class="collapseDiv">
 
                     <label for="zhedie-toggle3">Method</label>
 
                     <label for="zhedie-toggle3">Method</label>
Line 951: Line 951:
 
                         2. Count the cells using a hemocytometer. Seed in 24-well (5 × 10^4 per well) and grow.<br>
 
                         2. Count the cells using a hemocytometer. Seed in 24-well (5 × 10^4 per well) and grow.<br>
 
                         <b>Transfection</b> <br>
 
                         <b>Transfection</b> <br>
                         1. Dilute 0.5 μg DNA into 50 μl jetPRIME® buffer (supplied). Mix by vortexing.<br>
+
                         1. Dilute 0.5 μg DNA into 50 μl jetPRIME<sup>®</sup> buffer (supplied). Mix by vortexing.<br>
 
                         2. Add 1 μl jetPRIME®, vortex for 10 s, spin down briefly.<br>
 
                         2. Add 1 μl jetPRIME®, vortex for 10 s, spin down briefly.<br>
 
                         3. Incubate for 10 min at RT.<br>
 
                         3. Incubate for 10 min at RT.<br>
Line 980: Line 980:
 
                         4. Equilibrate the plate and its contents at room temperature for approximately 30 minutes
 
                         4. Equilibrate the plate and its contents at room temperature for approximately 30 minutes
 
                         after 20 h.<br>
 
                         after 20 h.<br>
                         5. Add a volume of CellTiter-Glo® Reagent equal to the volume of cell culture medium present in
+
                         5. Add a volume of CellTiter-Glo<sup>®</sup> Reagent equal to the volume of cell culture medium present in
 
                         each well. (add 100 μl of reagent to 100 μl of medium containing cells for a 96-well plate).<br>
 
                         each well. (add 100 μl of reagent to 100 μl of medium containing cells for a 96-well plate).<br>
 
                         6. Mix contents for 2 minutes on an orbital shaker to induce cell lysis.<br>
 
                         6. Mix contents for 2 minutes on an orbital shaker to induce cell lysis.<br>
Line 1,012: Line 1,012:
 
                         2. Count the cells using a hemocytometer. Seed in 24-well (9× 10^4 per well) and grow
 
                         2. Count the cells using a hemocytometer. Seed in 24-well (9× 10^4 per well) and grow
 
                         overnight.<br>
 
                         overnight.<br>
                         <b>Preparation of Bacteria</b> <br>
+
                         <b>Preparation of Bacterial Cells</b> <br>
                         1. Grow bacteria overnight 16 h in 2 mL LB in a 15-mL tube. Incubate at 37 °C in a shaking
+
                         1. Grow bacterial cells overnight 16 h in 2 mL LB in a 15-mL tube. Incubate at 37 °C in a shaking
 
                         incubator (200 rpm).<br>
 
                         incubator (200 rpm).<br>
                         2. Subculture bacteria by transferring 300 μL of the overnight culture into 5 mL of LB in a
+
                         2. Subculture bacterial cells by transferring 300 μL of the overnight culture into 5 mL of LB in a
 
                         loosely capped 50-mL tube. Incubate at 37 °C in a shaking incubator (200 rpm) to late log
 
                         loosely capped 50-mL tube. Incubate at 37 °C in a shaking incubator (200 rpm) to late log
 
                         phase.<br>
 
                         phase.<br>
Line 1,024: Line 1,024:
 
                         <b>Infection</b> <br>
 
                         <b>Infection</b> <br>
 
                         1. Aspirate media and rinse the monolayer twice with PBS.<br>
 
                         1. Aspirate media and rinse the monolayer twice with PBS.<br>
                         2. Inoculate cells with bacteria (MOI = 100) by adding bacteria directly to the cell-culture
+
                         2. Inoculate cells with bacterial cells (MOI = 100) by adding bacterial cells directly to the cell-culture
 
                         supernatant.<br>
 
                         supernatant.<br>
 
                         3. Incubate for 3 h at 37 °C in 5% CO<sub>2</sub>.<br>
 
                         3. Incubate for 3 h at 37 °C in 5% CO<sub>2</sub>.<br>
Line 1,037: Line 1,037:
 
                     serovar Typhimurium str. SL1344 Δ<i>sifA</i> is under the control of P<sub>tet</sub>. The
 
                     serovar Typhimurium str. SL1344 Δ<i>sifA</i> is under the control of P<sub>tet</sub>. The
 
                     colony-forming unit (CFU)
 
                     colony-forming unit (CFU)
                     was measured for counting the number of viable bacteria (<b>Figure 9</b>). This result shows that
+
                     was measured for counting the number of viable bacterial cells (<b>Figure 9</b>). This result shows that
 
                     eGFP-GSDMD-N275 exhibits cytotoxicity in bacteria.</p>
 
                     eGFP-GSDMD-N275 exhibits cytotoxicity in bacteria.</p>
 
                 <div style="width: 40%; margin: 0px auto">
 
                 <div style="width: 40%; margin: 0px auto">
Line 1,044: Line 1,044:
 
                 <p><b>Figure 9.</b> CFU comparison between the SL1344 Δ<i>sifA</i> cells with eGFP-GSDMD-N275 plasmid
 
                 <p><b>Figure 9.</b> CFU comparison between the SL1344 Δ<i>sifA</i> cells with eGFP-GSDMD-N275 plasmid
 
                     and with the
 
                     and with the
                     empty vector. In each group, ATc (15μg/ml) was added into medium when bacteria grown to logarithmic
+
                     empty vector. In each group, ATc (15μg/ml) was added into medium when bacterium grown to logarithmic
                     phase (OD = 0.6~0.8). Vector refers to bacteria containing a high copy number plasmid which only
+
                     phase (OD = 0.6~0.8). Vector refers to bacterium containing a high copy number plasmid which only
                     express TetR under the control of P<sub>tet</sub>. Bacterial colony-forming units (CFU) for vector
+
                     express TetR under the control of P<sub>tet</sub>. CFU for vector
 
                     and eGFP-GSDMD-N275 are shown in the logarithmic form (log10) (n=3).</p>
 
                     and eGFP-GSDMD-N275 are shown in the logarithmic form (log10) (n=3).</p>
 
                 <div class="collapseDiv">
 
                 <div class="collapseDiv">
Line 1,067: Line 1,067:
 
                     promoter in Δ<i>sifA</i> SL1344. Hela GSDMD KO cells were infected with Δ<i>sifA</i> SL1344.
 
                     promoter in Δ<i>sifA</i> SL1344. Hela GSDMD KO cells were infected with Δ<i>sifA</i> SL1344.
 
                     Inducer ATc
 
                     Inducer ATc
                     (16μg/mL) were added 3h after infection. Microscopy shows that eGFP-GSDMD-N275 locates in cytoplasm
+
                     (16μg/mL) were added 3h after infection. Microscopy shows that eGFP-GSDMD-N275 located in cytoplasm
                     after 5 min of induction and trigger pyroptosis after 30 min of induction (<b>Figure 10</b>). After
+
                     after 5 min of induction and triggered pyroptosis after 30 min of induction (<b>Figure 10</b>). After
 
                     1.5 h
 
                     1.5 h
                     of induction, Hela GSDMD KO cells undergo second necrosis caused by bacterial infection without
+
                     of induction, Hela GSDMD KO cells underwent second necrosis caused by bacterial infection without
 
                     inducer. Morphology of this process is similar to pyroptosis<sup>4</sup>. Thus, the population of
 
                     inducer. Morphology of this process is similar to pyroptosis<sup>4</sup>. Thus, the population of
 
                     ruptured
 
                     ruptured
Line 1,083: Line 1,083:
 
                 <p><b>Figure 10.</b> Hela GSDMD KO cells were infected with Δ<i>sifA</i> SL1344 containing high copy
 
                 <p><b>Figure 10.</b> Hela GSDMD KO cells were infected with Δ<i>sifA</i> SL1344 containing high copy
 
                     number plasmids
 
                     number plasmids
                     which express eGFP-GSDMD-N275 under the control of ATc. Photos were captured 5 min, 30min, 1.5h
+
                     which express eGFP-GSDMD-N275 under the control of ATc. Photographs were captured 5 min, 30 min, 90 min
 
                     after induction, respectively.</p>
 
                     after induction, respectively.</p>
 
                 <div style="width: 40%; margin: 0px auto">
 
                 <div style="width: 40%; margin: 0px auto">

Revision as of 17:27, 17 October 2018

Chassis
sifA knock out

SifA maintains the integrity of Salmonella-containing vacuole (SCV) where Salmonella survive and replicate1. The existence of SCV limits the releasing of GSDMD-N275 into cytoplasm. In addition, the growth of inhibition of ΔsifA mutant in macrophage is remarkable2. Thus, we knocked out the sifA gene in order to prevent the stability of SCV and reduce the virulence of Salmonella.

ΔsifA mutant was constructed by using gene editing system based on two-step allelic exchange3.

PCR verification indicated that chromosomal gene sifA was knocked out (Figure 1). Primers named DSIFA F and DSIFA R were used in this PCR (Figure 2).

Figure 1. PCR verification of sifA gene knock out. Lane 1 refers to ΔsifA mutant. Lane 2 refers to WT Salmonella enterica serovar Typhimurium strain SL1344 as a control.

Figure 2. DSIFA F and DSIFA R are the primers in the ORF of sifA. This pair of primers can extend a 436bp product in WT.

Safety

SifA is essential for maintaining vacuolar membrane stability. Cytosolic bacterium can be generated by the function loss of SCV. This population of bacterium was easily recognized and cleaned up by macrophage. Hence, ΔsifA mutant decrease the toxicity to the host. Microscopy demonstrated that ΔsifA mutant was defective for replication in macrophage (Figure 3).

Figure 3. Microscopy of immortalized bone-marrow-derived macrophages (iBMDM) infected with the ΔsifA mutant and WT Salmonella SL1344, respectively. These strains contain high copy number plasmids to express RFP constitutively.

Preparation of Cells for Infection
1. Grow iBMDMs in a humidified 37 °C, 5% CO2 tissue-culture incubator.
2. Count the cells using a hemocytometer. Seed in 24-well (5×10^4 per well) and grow overnight .
Preparation of the Bacterial Cells 1. Grow bacterial cells overnight 16 h in 2 mL LB in a 15-mL tube. Incubate at 37 °C in a shaking incubator (200 rpm).
2. Subculture bacterial cells by transferring 300 μL of the overnight culture into 5 mL of LB in a loosely capped 50-mL tube. Incubate at 37 °C in a shaking incubator (200 rpm) to late log phase.
3. Pellet 1 mL of the Salmonella bacteria cells subculture by centrifugation at 1,000×g in a microfuge for 2 min at room temperature.
4. Remove 900 μL of supernatant and gently resuspend the pellet in 900 μL PBS.
Infection 1. Aspirate media and rinse the monolayer twice with PBS.
2. Inoculate cells with bacterial cells (MOI = 20) by adding bacterial cells directly to the cell-culture supernatant. Centrifugate at 110 g for 5 min at room temperature.
3. Incubate for 25 min at 37 °C in 5% CO2.
4. Aspirate media and rinse the monolayer twice with PBS, to remove extracellular bacterial cells.
5. Add fresh GM containing 100 μg/mL gentamicin and incubate for 2 h at 37 °C in 5% CO2.
6. Replace GM with fresh GM containing 20 μg/mL gentamicin for remainder of experiment.
Observation is taken after 11 h.

Targeting

RGD motif can specifically bind to alpha V beta 3 (αVβ3), a well-known biomarker on the surface of tumor cells. We express RGD motif fused with OmpA to surface display it on the outer membrane of bacterial cells. Microscopy shows that bacterial cells expressed Lpp-OmpA-RGD induced by 0.1 mM IPTG can bind to αVβ3-positive MDA-MB-231 cell line. The location of bacterial cells is pointed by red arrow (Figure 4). But cannot bind to αVβ3-negative MCF7 cell line (Figure 5). These results demonstrated that the bacterium gain the function of tumor targeting though display RGD motif.

Figure 4. Microscopy of αVβ3-positive MDA-MB-231 cell line were incubated with E. coli which constructive expressed RFP and inductively expressed RGD motif under the control of Plac.

Figure 5. Microscopy of αVβ3-negative MCF7 cell line were incubated with E. coli which constructive expressed RFP and inductively expressed RGD motif under the control of lac promoter.

Preparation of Cells
1. Grow MDA-MB-231 and MCF7 in a humidified 37 °C, 5% CO2 tissue-culture incubator.
2. Count the cells using a hemocytometer. Seed in 24-well (1.5× 10^5 per well) and grow overnight.
Preparation of Bacterial cells 1. Grow bacterial cells overnight 14 h in 2 mL LB in a 15-mL tube. Incubate at 37 °C in a shaking incubator (200 rpm).
2. Subculture bacterial cells by transferring 300 μL of the overnight culture into 5 mL of LB containing 0.1 mM IPTG in a loosely capped 50-mL tube. Incubate at 37 °C in a shaking incubator (200 rpm) to early stationary phase.
3. Pellet 1 mL of the bacterial cells subculture by centrifugation at 1000 g in a microfuge for 2 min at room temperature.
4. Remove 900 μL of supernatant and gently resuspend the pellet in 900 μL PBS.
Infection 1. Aspirate media and rinse the monolayer twice with PBS.
2. Inoculate cells with bacterial cells (MOI = 100) by adding bacterial cells directly to the cell-culture supernatant.
3. Incubate for 1.5 h at 37 °C in 5% CO2.
4. Aspirate media and rinse the monolayer three times with PBS.
Observation is taken immediately.

Function of GSDMD
The N-terminal of GSDMD performs the function of cell pyroptosis

We fused eGFP with GSDMD-N275 (N-terminal 275 amino acid) and GSDMD FL (full length), respectively. Then the corresponding plasmids were transfected into Hela GSDMD KO cell. Cell microscopy showed that the cells transfected with GSDMD-N275 underwent pyroptosis while the cells with GSDMD FL did not (Figure 6). We also tested the cell viability through an ATP assay (CellTiter-Glo® Luminescent Cell Viability Assay) and demonstrated that GSDMD-N275 and mutants of GSDMD FL have different abilities to induce pyroptosis (Figure 7).

Figure 6. Microscopy of the Hela GSDMD KO cells transfected with pCS2-eGFP-GSDMD FL (above) and pCS2-eGFP-GSDMD-N275 (left), respectively. Pyroptotic cells are pointed by red arrow.

Preparation of Cells for transfection
1. Grow Hela GSDMD KO cells in a humidified 37 °C, 5% CO2 tissue-culture incubator.
2. Count the cells using a hemocytometer. Seed in 24-well (5 × 10^4 per well) and grow.
Transfection
1. Dilute 0.5 μg DNA into 50 μl jetPRIME® buffer (supplied). Mix by vortexing.
2. Add 1 μl jetPRIME®, vortex for 10 s, spin down briefly.
3. Incubate for 10 min at RT.
4. Add 50μl of transfection mix per well drop wise onto the cells in serum containing medium, and distribute evenly.
5. Gently rock the plates back and forth and from side to side.
6. If needed, replace transfection medium after 4 h by cell growth medium and return the plates to the incubator.
Observation is taken after 1.5 h.

Figure 7. Cell viability of the 293T cells transfected with pCS2-Flag-GSDMD FL, pCS2-Flag-GSDMD-N275, pCS2-Flag-GSDMD L290D, pCS2-Flag-GSDMD Y373D, pCS2-Flag-GSDMD A377D, respectively. Asterisks indicate the statistically significant differences. ATP-based cell viability was measured (n=6).

Preparation of Cells for ATP assay
1. Grow HEK293T cells in a humidified 37 °C, 5% CO2 tissue-culture incubator.
2. Count the cells using a hemocytometer. Seed in 96-well (1 × 10^4 per well) and grow overnight.
3. Transfect 0.5 μg DNA per well.
4. Equilibrate the plate and its contents at room temperature for approximately 30 minutes after 20 h.
5. Add a volume of CellTiter-Glo® Reagent equal to the volume of cell culture medium present in each well. (add 100 μl of reagent to 100 μl of medium containing cells for a 96-well plate).
6. Mix contents for 2 minutes on an orbital shaker to induce cell lysis.
7. Allow the plate to incubate at room temperature for 10 minutes to stabilize luminescent signal.
8. Record luminescence.

Induce the expression of GSDMD-N275
Intracellular environment-dependent expression

PsifA is a intracellular environment-dependent promoter. SipD is required for bacterial internalization. ΔsipD mutant cannot enter host cells. Thus, we use this strain as a control. Microscopy suggested that only intracellular bacteria express eGFP which under the control of PsifA (Figure 8).

Figure 8. Microscopy of hela GSDMD KO cells infected with the ΔsipD or ΔsifA mutant, respectively. These mutants contain low copy number plasmids to express eGFP which was regulated by PsifA

Preparation of Cells for Infection
1. Grow Hela GSDMD KO cells in a humidified 37 °C, 5% CO2 tissue-culture incubator.
2. Count the cells using a hemocytometer. Seed in 24-well (9× 10^4 per well) and grow overnight.
Preparation of Bacterial Cells
1. Grow bacterial cells overnight 16 h in 2 mL LB in a 15-mL tube. Incubate at 37 °C in a shaking incubator (200 rpm).
2. Subculture bacterial cells by transferring 300 μL of the overnight culture into 5 mL of LB in a loosely capped 50-mL tube. Incubate at 37 °C in a shaking incubator (200 rpm) to late log phase.
3. Pellet 1 mL of the Salmonella subculture by centrifugation at 1000 g in a microfuge for 2 min at room temperature.
4. Remove 900 μL of supernatant and gently resuspend the pellet in 900 μL PBS.
Infection
1. Aspirate media and rinse the monolayer twice with PBS.
2. Inoculate cells with bacterial cells (MOI = 100) by adding bacterial cells directly to the cell-culture supernatant.
3. Incubate for 3 h at 37 °C in 5% CO2.
4. Aspirate media and rinse the monolayer twice with PBS.
5. Add fresh GM containing 100 μg/mL gentamicin and incubate at 37 °C in 5% CO2. Observation is taken after 2 h.

ATc-dependent expression
GSDMD-N275 can lyses bacteria

Expression of the N-terminal of GSDMD fused with eGFP (eGFP-GSDMD-N275) in Salmonella enterica serovar Typhimurium str. SL1344 ΔsifA is under the control of Ptet. The colony-forming unit (CFU) was measured for counting the number of viable bacterial cells (Figure 9). This result shows that eGFP-GSDMD-N275 exhibits cytotoxicity in bacteria.

Figure 9. CFU comparison between the SL1344 ΔsifA cells with eGFP-GSDMD-N275 plasmid and with the empty vector. In each group, ATc (15μg/ml) was added into medium when bacterium grown to logarithmic phase (OD = 0.6~0.8). Vector refers to bacterium containing a high copy number plasmid which only express TetR under the control of Ptet. CFU for vector and eGFP-GSDMD-N275 are shown in the logarithmic form (log10) (n=3).

1. Bacteria are cultured overnight in LB broth containing corresponding antibiotics, and dilute each 1 volume overnight cultures with 100 volume fresh LB containing antibiotics. Culture in 37℃ 200 rpm.
2. When OD reaching to 0.6-0.8, add anhydrotetracycline with final concentration of μg/ml to induce the expression of EGFP-GSDMD-N275.
3. Take 100 μl diluted culture to plate on LB agar plates containing appropriate concentration of antibody after 1.5 hours of induce.
Observation is taken overnight.

GSDMD-N275 from lytic bacteria induces host cell pyroptosis

Expression of the N-terminal of GSDMD fused with eGFP (eGFP-GSDMD-N275) is under the control of tet promoter in ΔsifA SL1344. Hela GSDMD KO cells were infected with ΔsifA SL1344. Inducer ATc (16μg/mL) were added 3h after infection. Microscopy shows that eGFP-GSDMD-N275 located in cytoplasm after 5 min of induction and triggered pyroptosis after 30 min of induction (Figure 10). After 1.5 h of induction, Hela GSDMD KO cells underwent second necrosis caused by bacterial infection without inducer. Morphology of this process is similar to pyroptosis4. Thus, the population of ruptured cells was counted. There is 2-fold change between control group and induced group (Figure 11). So the pyroptosis of host cell in the induced group was triggered by eGFP-GSDMD-N275 not by bacterial infection.

In these experiment, the choice of MOI and infection time were conducted by Modelling.

Figure 10. Hela GSDMD KO cells were infected with ΔsifA SL1344 containing high copy number plasmids which express eGFP-GSDMD-N275 under the control of ATc. Photographs were captured 5 min, 30 min, 90 min after induction, respectively.

Figure 11. Numbers of pyroptotic cells before and after ATc induction. Ruptured cells in a field of view were counted.

Preparation of Cells for Infection
1. Grow Hela GSDMD KO cells in a humidified 37 °C, 5% CO2 tissue-culture incubator.
2. Count the cells using a hemocytometer. Seed in 24-well (5 × 10^4 per well) and grow overnight.
Preparation of Bacteria
1. Grow bacteria overnight 16 h in 2 mL LB in a 15-mL tube. Incubate at 37 °C in a shaking incubator (200 rpm).
2. Subculture bacteria by transferring 300 μL of the overnight culture into 5 mL of LB in a loosely capped 50-mL tube. Incubate at 37 °C in a shaking incubator (200 rpm) to late log phase.
3. Pellet 1 mL of the Salmonella subculture by centrifugation at 1000 g in a microfuge for 2 min at room temperature.
4. Remove 900 μL of supernatant and gently resuspend the pellet in 900 μL PBS.
Infection
1. Aspirate media and rinse the monolayer twice with PBS.
2. Inoculate cells with bacteria (MOI = 100) by adding bacteria directly to the cell-culture supernatant.
3. Incubate for 2 h at 37 °C in 5% CO2.
4. Aspirate media and wash.
5. Add fresh GM containing 100 μg/mL gentamicin and 16 μg/mL incubate at 37 °C in 5% CO2.
Observation is taken after 5 min, 30 min, 1.5 h.

Reference

1 Dumont, A. et al. SKIP, the host target of the Salmonella virulence factor SifA, promotes kinesin-1-dependent vacuolar membrane exchanges. Traffic 11, 899-911, doi:10.1111/j.1600-0854.2010.01069.x (2010).

2 Thurston, T. L. et al. Growth inhibition of cytosolic Salmonella by caspase-1 and caspase-11 precedes host cell death. Nature communications 7, 13292, doi:10.1038/ncomms13292 (2016).

3 Hmelo, L. R. et al. Precision-engineering the Pseudomonas aeruginosa genome with two-step allelic exchange. Nat Protoc 10, 1820-1841, doi:10.1038/nprot.2015.115 (2015).

4 He, W. T. et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion. Cell research 25, 1285-1298, doi:10.1038/cr.2015.139 (2015).

Description Design
Results

Chassis

Targeting

Function of GSDMD

Induce the expression of GSDMD-N275

Reference

Back to Top
Demonstrate